This is the full list of Late-Breaking Science sessions:
Sep 21st, 2021
Late-Breaking Science lineup this November
Seven late-breaking science sessions are on tap for Nov. 13-15.
(Abstracts have been accepted, but are pending confirmation by authors)
LBS.01 | Valves, Veins and New Viewpoints in Cardiothoracic Surgery
Aortic Valve Replacement Versus Watchful Waiting in Asymptomatic Severe Aortic Stenosis: The Avatar Trial (AVATAR)
Evaluating the Benefit of Concomitant Tricuspid Repair During Mitral Valve Surgery
A Randomized Study of Early Versus Standard Coronary Artery Bypass Surgery Among Patients Presenting With Acute Coronary Syndromes Treated With Ticagrelor (RAPID CABG)
Efficacy and Safety of an External Support Device for Saphenous Vein Coronary Bypass Grafts: The VEST Trial (VEST)
LBS.02 | Hypertension: Local, Global and Pandemic Impacts
A Remotely Delivered Hypertension and Lipid Program in 10,000 Patients Across a Diverse Health Care Network
Disruption in Blood Pressure Control With the Covid-19 Pandemic: A Study of 24 U.S. Health Systems in the PCORnet Blood Pressure Control Laboratory (BP Track)
A Cluster Randomized Trial of a Village Doctor-Led Intervention on Blood Pressure Control: China Rural Hypertension Control Project (CRHCP)
LBS.03 | Prevention to Intervention in Atrial Arrhythmias
The Coffee and Real-Time Atrial and Ventricular Ectopy (CRAVE) Trial (CRAVE)
Dabigatran Versus Warfarin on Cognitive Outcomes in Nonvalvular Atrial Fibrillation: Results of the GIRAF Trial. (GIRAF)
Posterior Left Pericardiotomy Reduces Postoperative Atrial Fibrillation After Cardiac Surgery (PALACS)
Outcomes of Adjunctive Left Atrial Appendage Ligation Utilizing the LARIAT Compared to Pulmonary Vein Antral Isolation Alone: The AMAZE Trial (AMAZE)
LBS.04 | Information Overload? Striving to Improve Care Delivery Through Digital Health and Automated Data
Risk Evaluation and its Impact on Clinical Decision-Making and Outcomes in Heart Failure: The REVeAL-HF Trial (REVeAL-HF)
Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study
Testing Individualized Triggers of Atrial Fibrillation: A Randomized Controlled Trial (I-STOP-AFib)
LBS.05 | Building on the Foundations of Treatment: Advances in Heart Failure Therapy
Heart Failure With a Preserved Ejection Fraction ≥50% - Results From the EMPEROR-Preserved Clinical Trial (EMPEROR-Preserved)
The Canagliflozin Impact on Health Status, Quality of Life and Functional Status in Heart Failure (CHIEF-HF) Clinical Trial (CHIEF-HF)
Efficacy and Safety of Empagliflozin in Hospitalized Heart Failure Patients: Main Results From the EMPULSE Trial (EMPULSE)
Randomized Trial of Targeted Transendocardial Delivery of Mesenchymal Precursor Cells in High-Risk Chronic Heart Failure Patients With Reduced Ejection Fraction (DREAM-HF)
LBS.06 | Fish Oil, Cocoa and Cholesterol: Recipes for CVD Prevention?
Icosapent Ethyl Versus Placebo in Outpatients With Covid-19: The Main Results of PREPARE-IT 2 (PREPARE-IT 2)
Primary Findings From the Cocoa Supplement and Multivitamin Outcomes Study (COSMOS) on the Prevention of Cardiovascular Disease (COSMOS)
The Clinical Safety, Pharmacokinetics and LDL-Cholesterol Lowering Efficacy of MK-0616, an Oral PCSK9 Inhibitor
LBS.07 | New Drugs and New Drug Indications in Cardiovascular Disease
Effects of Aspirin on Dementia and Cognitive Impairment in the ASCEND Trial (ASCEND)
P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19 (ACTIV-4A)
Effect Of Bentracimab on Platelet Inhibition and Hemostasis in Ticagrelor Patients With Uncontrolled Hemorrhage or Requiring Urgent Surgery in the REVERSE-IT (REVERSE-IT)
Milvexian for Prevention of Venous Thromboembolism After Elective Knee Arthroplasty: The AXIOMATIC-TKR Study (AXIOMATIC-TKR)
